Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Mallinckrodt
Colorcon
McKesson
McKinsey

Last Updated: March 30, 2023

Patent: 8,883,862


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions


Summary for Patent: 8,883,862
Title:Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel
Abstract: A method for locally controlled release of an effective amount of PTH(1-34) by a hyaluronic acid based hydrogel that can injected intra-articularly for the treatment of osteoarthritis is provided.
Inventor(s): Ho; Mei-Ling (Kaohsiung, TW), Eswaramoorthy; Rajalakshmanan (Kaohsiung, TW), Wu; Shun-Cheng (Kaohsiung, TW), Wang; Gwo-Jaw (Taipei, TW), Chang; Je-Ken (Kaohsiung, TW), Fu; Yin-Chih (Kaohsiung, TW), Tzeng; Cherng-Chyi (Kaohsiung, TW), Chen; Hui-Ting (Kaohsiung, TW), Wang; Yao-Hsien (Kaohsiung, TW)
Assignee: Kaohsiung Medical University (Kaohsiung, TW)
Application Number:13/349,533
Patent Claims:see list of patent claims

Details for Patent 8,883,862

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 01/23/2015 ⤷  Sign Up 2039-03-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
McKesson
Boehringer Ingelheim
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.